FAT1-associated membranous nephropathy after hematopoietic stem cell transplantation: a case report and review of the literature. (PubMed, CEN Case Rep) - Oct 1, 2026 - "The review showed variable onset timing, substantial proteinuria at presentation, inconsistent immunoglobulin G4 positivity, and heterogeneous treatment with corticosteroids, rituximab, calcineurin inhibitors, and other regimens. Our case and review indicate that this disease can present late, cannot be excluded by non-immunoglobulin G4-predominant staining, and remains heterogeneous in diagnostic evaluation, treatment, and outcomes. Further accumulation of cases is needed to clarify the clinical spectrum and optimal management of this disease."
Journal • Review • Acute Lymphocytic Leukemia • Bone Marrow Transplantation • Chronic Graft versus Host Disease • Glomerulonephritis • Graft versus Host Disease • Hematological Malignancies • Immunology • Leukemia • Nephrology • Oncology • Renal Disease • Respiratory Diseases • Transplantation • CDH23 • FAT1 • PCDH
|
|
Kan Katayama; Kaoru Dohi; Ryosuke Saiki; Tomohiro Murata; Yuto Matsui
|